89bio, Inc. (ETNB) Stock Price, News, Quote & History - Yahoo Finance
Oops, something went wrong
Skip to navigation
Skip to main content
Skip to right column
News
Today's news
US
Politics
World
Tech
Audio
Computing
Gaming
Gaming deals Nintendo PC PlayStation Wordle Xbox
Home entertainment
TVs
Phones
Science
Streaming
Streaming reviews
Tech News
VPN
Deals
More
AI Apps AR and VR Business Cameras Cyber security Entertainment General Reviews and guides Smart home Social media Transportation Wearables
Weather
Climate change
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Science
Originals
The 360
Newsletters
Games
Life
Health
Wellness
Nutrition Fitness Healthy aging Mental health Sleep
Your body
Dermatology Children's health Foot health Hair loss Hearing Oral health Sexual health Women’s health
Conditions
Cardiovascular health Digestive health Endocrine system
Parenting
Family health
So mini ways
Style and beauty
It Figures
Unapologetically
Horoscopes
Shopping
Style
Accessories Clothing Luggage Shoes
Beauty
Hair Makeup Skincare Sunscreen
Health
Dental Fitness Hair loss Hearing aids Mental health Mobility Nutrition Personal care Sleep Women's health
Home and garden
Bedding Cleaning Gardening Kitchen Outdoor
Pets
Tech
Accessories Audio Auto Computers Phones Smart home TVs
Gift ideas
Stores
Amazon Best Buy Home Depot Macy's Nordstrom Target Walmart Wayfair
Shopping Guides
Best non-toxic cutting boards Best heated socks Best body wash Best cordless stick vacuums Best makeup removers
Deals
Back to school
Food
Travel
Autos
Gift ideas
Buying guides
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My Portfolio
News
Latest
Stock Market
Originals
Crypto
Tariff Updates
Newsletters
Economies
Premium News
Earnings
Tech
Housing
Markets
Stocks: Most Actives
Stocks: Gainers
Stocks: Losers
Trending Tickers
Futures
World Indices
US Treasury Bonds Rates
Currencies
Crypto
Top ETFs
Top Mutual Funds
Options: Highest Open Interest
Options: Highest Implied Volatility
Sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Private Companies
Research
Screeners
Earnings Calendar
Economic Calendar
Stock Comparison
Advanced Chart
Currency Converter
Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards
Banking
Student Loans
Personal Loans
Insurance
Mortgages
Mortgage Calculator
Taxes
Videos
Latest
Trending Stocks
Market Sunrise
Morning Brief
Opening Bid
All Shows
Stocks in Translation
Trader Talk
Financial Freestyle
ETF Report
FA Corner
Options Playbook
Watch Now
Sports
Fantasy
News
Fantasy football
Best ball
Pro Pick 'Em
College Pick 'Em
Fantasy baseball
Fantasy hockey
Fantasy basketball
Download the app
Daily fantasy
NFL
News
Scores and schedules
Standings
Stats
Teams
Players
Drafts
Injuries
Odds
Super Bowl
GameChannel
Videos
NBA
News
Draft
Scores and schedules
Standings
Stats
Teams
Players
Injuries
Videos
Odds
Playoffs
MLB
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Videos
World Baseball Classic
NHL
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Playoffs
College football
News
Scores and schedules
Standings
Rankings
Stats
Teams
College basketball
Soccer
News
Scores and schedules
Premier League
MLS
NWSL
Liga MX
CONCACAF League
Champions League
La Liga
Serie A
Bundesliga
Ligue 1
World Cup
NFL Draft
Yahoo Sports AM
Show all
WNBA
Sportsbook
NCAAF
Tennis
Golf
NASCAR
NCAAB
NCAAW
Boxing
USFL
Cycling
Motorsports
Olympics
Horse racing
GameChannel
Rivals
Newsletters
Podcasts
Videos
RSS
Jobs
Help
World Cup
More news
New on Yahoo
Creators
Tech
Local services
Moving
Roofing
Painting
Plumbing
Terms
Privacy
Privacy Dashboard
Feedback
© 2025
All rights reserved.
About our ads
Advertising
Careers
Yahoo Finance
Yahoo Finance
Search query
Select edition
USEnglish
US y LATAMEspañol
AustraliaEnglish
CanadaEnglish
CanadaFrançais
DeutschlandDeutsch
FranceFrançais
香港繁中
MalaysiaEnglish
New ZealandEnglish
SingaporeEnglish
台灣繁中
UKEnglish
News
Finance
Sports
More News Today's news
US
Politics
World
Weather
Climate change
Health
Science
Originals
Newsletters
Games
Life Health
Parenting
Style and beauty
Horoscopes
Shopping
Food
Travel
Autos
Gift ideas
Buying guides
Entertainment Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance My portfolio
Watchlists
Markets
News
Videos
Screeners
Personal finance
Crypto
Sectors
Sports Fantasy
NFL
NBA
MLB
NHL
College football
College basketball
Soccer
NFL Draft
Yahoo Sports AM
New on Yahoo Creators Tech Local services
Selected edition
USEnglish
Mail
Sign in
My Portfolio
News
Latest Stock Market Originals Crypto Tariff Updates Newsletters Economies Premium News
Earnings Tech Housing
Markets
Stocks: Most Actives Stocks: Gainers Stocks: Losers Trending Tickers Futures World Indices US Treasury Bonds Rates Currencies Crypto Top ETFs Top Mutual Funds Options: Highest Open Interest Options: Highest Implied Volatility Sectors Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities Private Companies
Research
Screeners Earnings Calendar Economic Calendar Stock Comparison Advanced Chart Currency Converter Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards Banking Student Loans Personal Loans Insurance Mortgages Mortgage Calculator Taxes
Videos
Latest Trending Stocks Market Sunrise Morning Brief Opening Bid All Shows Stocks in Translation Trader Talk Financial Freestyle ETF Report FA Corner Options Playbook
Watch Now
…
Upgrade to Premium
ETNB 89bio, Inc.
15.01
+0.33%
Summary
News
Research
Chart
Community
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
We are experiencing some temporary issues. The market data on this page is currently delayed.
NasdaqGM - Nasdaq Real Time Price • USD
89bio, Inc. (ETNB)
Follow
Add holdings
Get top stock picks
14.96
+6.88
+(85.15%)
At close: September 18 at 4:00:02 PM EDT
15.01
+0.05
+(0.33%)
Overnight: 9:21:56 PM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Get top stock picks
Chart Range Bar
1D
5D
72.95%
1M
58.47%
6M
74.97%
YTD
91.30%
1Y
80.02%
5Y
-41.40%
All
-25.20%
Key Events
Mountain
Advanced Chart
Loading chart for ETNB
Chart does not reflect overnight price.
Previous Close 8.08
Open 14.98
Bid 10.78 x 200
Ask 19.17 x 200
Day's Range 14.94 - 15.06
52 Week Range 4.16 - 15.06
Volume 80,334,231
Avg. Volume 1,483,787
Market Cap (intraday) 2.219B
Beta (5Y Monthly) 1.27
PE Ratio (TTM) --
EPS (TTM) -3.69
Earnings Date Nov 6, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 35.12
89bio, Inc. Overview Biotechnology / Healthcare
89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia. The company was founded in 2018 and is headquartered in San Francisco, California. www.89bio.com
93 Full Time Employees December 31 Fiscal Year Ends Healthcare
Sector Biotechnology
Industry
More about 89bio, Inc.
Recent News: ETNB View More
All
News
Earnings Calls
Press Releases
SEC Filings
Stocks to Watch Recap: Intel, FedEx, Meta, Darden Restaurants
The Wall Street Journal • 4h ago
Roche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio Buyout
Investor's Business Daily • 5h ago
Sector Update: Health Care Stocks Advance Late Afternoon
PREMIUM MT Newswires • 5h ago
RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline
Zacks • 9h ago
89bio Stock Soars 86%. Why Roche Is Buying the Biopharma Company for $3.5 Billion.
Barrons.com • 11h ago
Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion
The Wall Street Journal • 11h ago
Wall Street Set to Open Higher Thursday; Jobless Claims Fall as Manufacturing Index Rebounds
PREMIUM MT Newswires • 11h ago
Stocks Gain Pre-Bell as Fed Lowers Rates, Signals Further Policy Easing in 2025
PREMIUM MT Newswires • 13h ago
89bio, Inc. Announces Agreement to be Acquired by Roche
GlobeNewswire • 20h ago
A Closer Look at 89bio (ETNB) Valuation Following Recent Share Price Drift
Simply Wall St. • 1d ago
H.C. Wainwright Backs 89bio (ETNB) with Buy Rating
Insider Monkey • 10d ago
View More
Performance Overview: ETNB
Trailing total returns as of 9/18/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC)
.
YTD Return
ETNB 91.30%
S&P 500 (^GSPC) 12.76%
1-Year Return
ETNB 80.02%
S&P 500 (^GSPC) 18.04%
3-Year Return
ETNB 137.46%
S&P 500 (^GSPC) 71.22%
5-Year Return
ETNB 41.40%
S&P 500 (^GSPC) 99.79%
Compare To: ETNB Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
ETNB 89bio, Inc.
14.96 +85.15%
Mkt Cap
2.219B
Industry Biotechnology
AKRO Akero Therapeutics, Inc.
46.20 +9.53%
Mkt Cap
3.695B
Industry Biotechnology
XNCR Xencor, Inc.
10.03 +8.43%
Mkt Cap
715.37M
Industry Biotechnology
DAWN Day One Biopharmaceuticals, Inc.
7.21 +3.15%
Mkt Cap
738.534M
Industry Biotechnology
NRIX Nurix Therapeutics, Inc.
8.97 +4.67%
Mkt Cap
685.751M
Industry Biotechnology
RAPT RAPT Therapeutics, Inc.
20.50 +13.89%
Mkt Cap
339.025M
Industry Biotechnology
VRDN Viridian Therapeutics, Inc.
19.62 +5.37%
Mkt Cap
1.602B
Industry Biotechnology
PHAT Phathom Pharmaceuticals, Inc.
11.75 +6.82%
Mkt Cap
833.589M
Industry Biotechnology
PRTA Prothena Corporation plc
8.18 +1.49%
Mkt Cap
440.329M
Industry Biotechnology
FULC Fulcrum Therapeutics, Inc.
7.54 +3.01%
Mkt Cap
407.851M
Industry Biotechnology
RLAY Relay Therapeutics, Inc.
4.5500 +11.25%
Mkt Cap
784.472M
Industry Biotechnology
Statistics: ETNB View More
Valuation Measures
Current
Quarterly
Annual
As of 9/17/2025 Market Cap
1.20B
Enterprise Value
674.79M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales
(ttm) --
Price/Book
(mrq) 2.30
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets
(ttm) -49.10%
Return on Equity
(ttm) -86.86%
Revenue
(ttm) --
Net Income Avi to Common
(ttm) -450.21M
Diluted EPS
(ttm) -3.69
Balance Sheet and Cash Flow
Total Cash
(mrq) 561.16M
Total Debt/Equity
(mrq) 7.21%
Levered Free Cash Flow
(ttm) -257.73M
View More
Research Analysis: ETNB View More
Earnings Per Share
Consensus EPS
Revenue vs. Earnings
Revenue --
Earnings -111.5M
Q324
Q424
Q125
Q225
-100M
-50M
0
Analyst Recommendations
Strong Buy
Buy
Hold
Underperform
Sell
Analyst Price Targets
15.00
35.12 Average
14.96 Current
55.00 High
View More
Research Reports: ETNB
View More
Daily – Vickers Top Insider Picks for 02/21/2025
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Argus• 6 months ago
Daily – Vickers Top Buyers & Sellers for 01/24/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Argus• 7 months ago
Daily – Vickers Top Buyers & Sellers for 07/09/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Argus• 4 years ago
View More
People Also Watch
AKRO
Akero Therapeutics, Inc.
46.20 +9.53%
PHAT
Phathom Pharmaceuticals, Inc.
11.75 +6.82%
CABA
Cabaletta Bio, Inc.
2.1800 +13.54%
IDYA
IDEAYA Biosciences, Inc.
26.22 +7.28%
MIRM
Mirum Pharmaceuticals, Inc.
75.32 +2.98%
Copyright © 2025 Yahoo. All rights reserved.
What's trending Dow Jones
S&P 500
DAX Index
Nvidia
Tesla
DJT
Tariffs
Explore more Mortgages
Credit Cards
Sectors
Crypto Heatmap
Financial News
About Data Disclaimer
Help
Feedback
Sitemap
Licensing
What's New
About Our Ads
Premium Plans
Terms
and Privacy Policy
Privacy Dashboard
More Info
U.S. markets closed
US
Europe
Asia
Cryptocurrencies
Rates
Commodities
Currencies
S&P Futures
6,697.00 +3.50 (+0.05%)
Dow Futures
46,541.00 +25.00 (+0.05%)
Nasdaq Futures
24,709.75 +4.25 (+0.02%)
Russell 2000 Futures
2,490.70 +3.20 (+0.13%)
VIX
15.70 -0.02 (-0.13%)
Gold
3,680.70 +2.40 (+0.07%)
Portfolio
Portfolio
Sign in to access your portfolio Sign in
Top gainers
ETNB 89bio, Inc. 14.96 +6.88 (+85.15%)
TIC Acuren Corporation 13.45 +2.51 (+22.94%)
INTC Intel Corporation 30.57 +5.67 (+22.77%)
BLSH Bullish 65.61 +11.26 (+20.72%)
QS QuantumScape Corporation 12.13 +1.87 (+18.23%)
Top losers
QMMM QMMM Holdings Limited 89.02 -16.62 (-15.73%)
YPF YPF Sociedad Anónima 24.41 -2.83 (-10.39%)
FDS FactSet Research Systems Inc. 301.23 -34.81 (-10.36%)
TEO Telecom Argentina S.A. 6.52 -0.66 (-9.19%)
SGHC Super Group (SGHC) Limited 11.69 -1.14 (-8.89%)
Most active
INTC Intel Corporation 30.57 +5.67 (+22.77%)
OPEN Opendoor Technologies Inc. 9.94 -0.27 (-2.64%)
SNAP Snap Inc. 8.44 +0.45 (+5.63%)
NVDA NVIDIA Corporation 176.24 +5.95 (+3.49%)
PLUG Plug Power Inc. 2.1000 +0.0900 (+4.48%)
Earnings events
My earnings events
Earnings events
Trending tickers
INTC Intel Corporation 30.57 +5.67 (+22.77%)
QS QuantumScape Corporation 12.13 +1.87 (+18.23%)
FDX FedEx Corporation 226.50 +0.72 (+0.32%)
OKLO Oklo Inc. 104.97 +9.68 (+10.16%)
LEN Lennar Corporation 132.87 -0.10 (-0.08%)
Top economic events
Top economic events
United States
Fed Funds Tgt Rate
Sep 17, 2025, 2:00 PM EDT Prior: P: 4.38 New: N: 4.25
Fed Funds Tgt Rate
Sep 17, 2025, 2:00 PM EDT Prior: Prior: 4.38 New: New: 4.25
Edit your Dock
Terms
and Privacy Policy
Privacy Dashboard
Ad Terms
Feedback
More Info